Thomas Engleitner

Technical University of Munich — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index6.1kcitations115works10.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(21), Histone Deacetylase Inhibitors Research(17), Pancreatic and Hepatic Oncology Research(16), Advanced Breast Cancer Therapies(14), Immune Cell Function and Interaction(10)

Publications115 total

Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury
Signal Transduction and Targeted Therapy·2025Open Access
Exploiting TGF-β-mediated Stromal Programming in Homologous Recombination-Deficient Pancreatic Cancer
2025Open Access
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancer
Gut·2025· 3 cited
Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis
Immunity·2024· 6 citedOpen Access
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma
Nature Biomedical Engineering·2024· 21 citedOpen Access
CDK4/6 inhibition initiates cell cycle arrest by nuclear translocation of RB and induces a multistep molecular response
Cell Death Discovery·2024· 8 citedOpen Access
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury
2024
FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells
Leukemia·2024· 2 citedOpen Access
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection
Nature·2024· 56 citedOpen Access
Mutual regulation of CD4+ T cells and intravascular fibrin in infections
Haematologica·2024· 1 citedOpen Access
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Nature Communications·2024Open Access
Corrigendum to “A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer” [Bioorgan. Chem. 119 (2022) 105505]
Bioorganic Chemistry·2024· 2 citedOpen Access
Genome-scale pan-cancer interrogation of lncRNA dependencies using CasRx
Nature Methods·2024· 33 citedOpen Access
Systematic <scp>P2Y</scp> receptor survey identifies <scp>P2Y11</scp> as modulator of immune responses and virus replication in macrophages
The EMBO Journal·2023· 7 citedOpen Access
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression
Cell Reports·2023· 20 citedOpen Access
High RIPK3 expression is associated with a higher risk of early kidney transplant failure
iScience·2023· 1 citedOpen Access
PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation
Nature Communications·2023· 64 citedOpen Access
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy
Cell Reports Medicine·2023· 20 citedOpen Access
mRNA 3’UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virus
Nature Communications·2023· 16 citedOpen Access
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Nature Communications·2023· 46 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Roland Rad(44), Rupert Öllinger(22), Katja Steiger(16), Dieter Saur(14), Günter Schneider(12), Sebastian Lange(9), Roland M. Schmid(8), Wilko Weichert(7), Jürgen Ruland(7), Florian Bassermann(7), Maximilian Reichert(7), Kristian Unger(6), Bernhard Küster(6), Julia Weber(6), Roman Maresch(6), Mathias Friedrich(6), George S. Vassiliou(6), Julia Slotta‐Huspenina(5), Sebastian Mueller(5), Fengtang Yang(5)